EORTC - "Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer"

EisaI Inc, USA- Oncodesign France

DOWNLOAD

EORTC - "Anti tumour activity of new antibody drug conjugate (ADC) with eribulin in triple negative breast cancer (TNBC) patient-derived xenograft (PDX)"

Oncodesign, France- Morphotek, USA -  Eisai, Japon

DOWNLOAD

EANM 2017 - " In vitro and in vivo evaluation of two enantiomers of Nanocyclix® EGFR targeted PET radiotracer”

Oncodesign, Dijon - Pharmimage, Dijon - Cyclopharma Laboratories, St Beauzire - Centre Georges François Leclerc, Dijon -  Centre Hospitalier Universitaire François Mitterand, Dijon.

DOWNLOAD